UBS Group AG - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALTW and the CUSIP is 363225111. A total of 4 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$02,112
-27.5%
0.00%
Q3 2016$02,912
+873.9%
0.00%
Q2 2016$0299
-0.3%
0.00%
Q1 2016$0
-100.0%
300
-72.9%
0.00%
Q1 2015$1,0001,108
+233.7%
0.00%
Q4 2014$03320.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 643,800$1,461,0000.00%
Neuberger Berman Group LLC 129,700$294,0000.00%
Tower Research Capital LLC (TRC) 889$2,0000.00%
UBS AG 1,355$3,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders